secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0000950170-23-029499
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Graphite Bio CFO Alethia Young resigns; CEO Josh Lehrer to assume PFO/PAO roles
-------------------------------------------------------------------------------

- Alethia Young resigns as CFO, effective June 30, 2023, to pursue other opportunities.
- Resignation not related to any disagreement with the company or its management.
- CEO Josh Lehrer appointed as Principal Financial Officer and Principal Accounting Officer effective July 1, 2023.
- Dr. Lehrer has served as CEO since April 2020; prior roles at Global Blood Therapeutics and Genentech.
- Ms. Young will remain through June 30 to ensure orderly transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000095017023029499/0000950170-23-029499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000095017023029499/grph-20230623.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-029499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer